-+ 0.00%
-+ 0.00%
-+ 0.00%

Eupraxia Pharmaceuticals Q1 EPS $(0.21) Beats $(0.23) Estimate

Benzinga·05/06/2025 22:12:27
Listen to the news
Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.23) by 8.7 percent. This is unchanged from the same period last year.